Valerie Taylor

This study uses CEST MRI to noninvasively monitor proteasome inhibitor response in mouse tumor models, showing increased CEST signals with higher drug doses and varying tumor sensitivity.

This paper introduces DLDF, a deep learning method that detects brain tumor response to chemotherapy using diffusion-weighted MRI in a mouse model, showing it can segment tumors, distinguish tumor age, and detect chemotherapy effects with limited data.

This study evaluates VERDICT MRI for detecting early response to Temozolomide therapy in brain tumours, showing it is more sensitive than structural or ADC measurements.